Insomnia Disorder Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Insomnia Disorder Epidemiology Forecast Report Coverage

Expert Market Research's “Insomnia Disorder Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of insomnia disorder. It projects the future incidence and prevalence rates of insomnia disorder cases across various populations. The study covers age, gender, and type as major determinants of the insomnia disorder population. The report highlights patterns in the prevalence of insomnia disorder over time and projects future trends based on multiple variables.

Insomnia Disorder Understanding: Disease Overview

Insomnia disorder is a sleep disorder characterized by persistent difficulty falling asleep, staying asleep, or waking too early, despite having adequate opportunity to sleep, with associated daytime impairment. It can occur independently or alongside medical, psychiatric, or other sleep conditions. Common forms include sleep-onset insomnia, sleep-maintenance insomnia, and early-morning awakening insomnia. Chronic insomnia disorder generally involves symptoms occurring at least three nights per week for at least three months. Sleep disturbance may be associated with stress, anxiety, depression, irregular sleep schedules, medical conditions, medications, or environmental factors.

Key Report Insights

Insomnia Disorder Epidemiology Perspective

The insomnia disorder epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the insomnia disorder epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for insomnia disorder and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Type-Specific Disease Burden and Epidemiology Analysis

Read more about this report - Request a Free Sample

Country-wise Insomnia Disorder Epidemiology

The insomnia disorder epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

The insomnia disorder landscape presents significant opportunities to improve early diagnosis, treatment access, and long-term disease management. Underdiagnosis remains an important gap because many individuals experiencing persistent sleep difficulties do not receive formal assessment or evidence-based treatment. Expanding access to CBT-I, particularly through digitally delivered and guided programs, represents an important opportunity across the United States, Europe, Japan, and India. Integrating insomnia screening into primary care and mental health services could improve identification of patients with persistent symptoms. India also offers substantial growth potential through greater sleep-health awareness, improved screening, and expansion of specialized sleep-care services.

Insomnia Disorder: Treatment Overview

Insomnia treatment primarily focuses on behavioral and psychological interventions, with cognitive behavioral therapy for insomnia (CBT-I) recommended as the first-line treatment for chronic insomnia in adults. CBT-I combines cognitive restructuring, stimulus control, sleep restriction, relaxation techniques, and sleep-hygiene education. Digital CBT-I may also improve access to treatment. When CBT-I is unavailable or insufficient, clinicians may consider short-term pharmacological treatment based on individual needs, risks, and comorbidities. Treatment may also involve addressing underlying medical or psychiatric conditions, maintaining regular sleep schedules, and improving sleep-related behaviors.

Key Questions Answered

• What is the current and projected burden of insomnia disorder across the 8 major markets?
• Which countries across the 8 major markets account for the highest insomnia disorder patient populations and fastest growth rates?
• What is the diagnosed versus undiagnosed patient population of insomnia disorder across key countries in the 8 major markets?
• Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of insomnia disorder across the 8 major markets?
• What are the major drivers contributing to the increasing burden of insomnia disorder across the 8 major markets?
• How do major comorbidities and risk factors influence insomnia disorder epidemiology trends across the 8 major markets?
• What are the regional trends in advanced disease progression, treatment uptake, and patient management of insomnia disorder across the 8 major markets?
• Which patient segments represent the highest unmet clinical need in the insomnia disorder landscape across the 8 major markets?
• Which therapeutic areas linked to insomnia disorder are expected to witness the strongest growth opportunities across the 8 major markets?
• How is the insomnia disorder epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
• Which countries across the 8 major markets offer the most attractive market opportunities based on insomnia disorder epidemiology and healthcare infrastructure?
• Which epidemiological trends are expected to influence future drug development and market access strategies for insomnia disorder across the 8 major markets?

Scope of the Insomnia Disorder Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of insomnia disorder based on several factors.
• Insomnia Disorder Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The insomnia disorder report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Insomnia Drug Pipeline Analysis

Neurological Disease Treatment Market